Invicro is a next-generation quantitative imaging biomarker company focused on accelerating the drug discovery and development process for pharmaceutical and biotech companies. Our solutions allow researchers to visualize and quantitate drug targets, evaluate and measure drug delivery, monitor and quantify drug effects, and assess and predict drug response. We design, execute, analyze, and report on clinical trials using advanced imaging endpoints functions across discovery, preclinical, translational and Phase I-IV trials.

Contact us